CSat Investment Advisory’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,809
Closed -$179K 1096
2019
Q3
$179K Buy
1,809
+192
+12% +$18.2K 0.06% 219
2019
Q2
$149K Buy
1,617
+1,555
+2,508% +$148K 0.05% 227
2019
Q1
$6K Sell
62
-16
-21% -$1.4K ﹤0.01% 494
2018
Q4
$5K Buy
78
+42
+117% +$3.1K ﹤0.01% 494
2018
Q3
$3K Sell
36
-3
-8% -$265 ﹤0.01% 516
2018
Q2
$3K Buy
+39
New +$3.24K ﹤0.01% 518

Other funds holding CELG

CSat Investment Advisory's CELG Position: Q4 2019 in Review

CSat Investment Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,809 shares — an estimated $179K sold.

CSat Investment Advisory first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $179K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • CSat Investment Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • CSat Investment Advisory sold 1,809 Celgene Corp shares in Q4 2019, an estimated $179K.
  • CSat Investment Advisory first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
  • CSat Investment Advisory's Celgene Corp position peaked at $179K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on CSat Investment Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.